source
- Dementia finally shows a viable business model, AAIC2026 highlights economic shiftAt the Alzheimer’s Association International Conference in London this year, the author observed that dementia now appears to have a clear business model, a shift from earlier meetings where commer…
- CHMP recommends Minoryx’s ALD drug, rejects Zevra’s MeplyffaMinoryx Therapeutics finally scored backing from EU regulators for its neurological drug that’s faced multiple hurdles. Meanwhile, Zevra’s rare disease drug got a setback in Europe almost two years…Endpoints · 7d ago↗ source
- GSK walks away from Alector pact as immuno-neurology bet fizzles